Clinical Trials in Maryland

Showing 2501-2520 of 19,983 trials

Diet, Hepcidin, and Chemotherapy RDI

NCT06483997

This prospective, observational cohort study will evaluate the extent of associations between self-reported pro- or anti- inflammatory dietary intake patterns for one month before induction chemotherapy for gynecological cancer or neo/adjuvant chemotherapy for breast cancer and baseline serum hepcidin concentrations. Associations between hepcidin concentration and relative dose intensity (RDI) of chemotherapy will also be evaluated.

Breast Cancer FemaleOvarian CancerFallopian Tube Cancer+3 more

George Washington University100 participantsStarted Aug 2024

Washington D.C., District of Columbia, United States

COMPLETEDPhase 2/319 miles

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

NCT05721573

A Phase II/III Randomized, Double-blind, Placebo-controlled, Multicenter Study to Determine the Efficacy and Safety of ABC008 in the Treatment of Subjects with Inclusion Body Myositis

Inclusion Body Myositis

Abcuro, Inc.272 participantsStarted Feb 2023

Phoenix, Arizona, United States • Irvine, California, United States • Los Angeles, California, United States +42 more locations

Diet, Hepcidin, and Chemotherapy RDI

A Study to Evaluate the Efficacy and Safety of ABC008 for Inclusion Body Myositis

Find Trials by Condition in Maryland

Immunobiology Blood and Tissue Collection of Upper Aerodigestive Malignancies

Safety and Feasibility of TA-CIN Vaccine in HPV16 Associated Cervical Cancer

OsteoPorotic fracTure preventION System (OPTIONS) Research Study

Optimal Pediatric Heart Transplant Immunosuppression With MicroRNAs

Assessing an Oral EGFR Inhibitor, Sunvozertinib in Patients Who Have Advanced Non-small Cell Lung Cancer With EGFR or HER2 Mutation (WU-KONG1)

A Study of PHN-010 in Patients With Advanced Solid Tumors

Study to Compare Efficacy, Safety, and Immunogenicity of LUBT010 (Proposed Ranibizumab Biosimilar) and Lucentis® in Patients With Neovascular AMD

A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy

Phase III Study Assessing the Efficacy and Safety of Pegcetacoplan in Patients With C3 Glomerulopathy or Immune-Complex Membranoproliferative Glomerulonephritis

A Study in Patients Previously Enrolled in a Genentech and/or F. Hoffmann-La Roche Ltd Sponsored Atezolizumab Study

A Study of HMPL-306 in Advanced Hematological Malignancies With mIDH

A Study of Modakafusp Alfa (TAK-573) Given by Itself and Together With Pembrolizumab in Adults With Advanced or Metastatic Solid Tumors

Multicenter Trial of ECMO in Children With Severe Cardiac Failure Using the Cardiohelp System

A Study of a Novel Iron-based Phosphate Binder AP301 in Patients With Hyperphosphatemia in the U.S. and China

A Clinical Trial of PRAX-562 in Subjects With Developmental and Epileptic Encephalopathies (DEE)

A Study of Eptinezumab in Participants With Migraine and Medication Overuse Headache

Phase 1/2a Study to Assess the Safety, Tolerability, Pharmacokinetics, and Preliminary Efficacy of WEF-001 as Monotherapy in Advanced KRAS-Mutant Solid Tumours.

BCL2i CLAG-M in R/R Acute Myeloid Leukemia